Team reports how gene editing iPS cells can lead to a universal cancer immunotherapy product
Cancer immunotherapies have made the news for their startling effectiveness against certain cancers. However, current clinical therapies mainly use the patient's own cells, limiting the number of patients who have access ...
May 18, 2021
0
10